Correction Of Glucose-6-Phosphate Dehydrogenase (G6PD) Viangchan Mutation In Monocytes Using CRISPR/CAS9
G6PD deficiency is one of the most common enzymopathy in human with approximately 400 million people affected worldwide. Two hundred seventeen types of mutations have been described so far with some mutations are life threating. G6PD deficiency has also been linked to various types of cancers, tumou...
Main Author: | Vengidasan, Lelamekala |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | http://eprints.usm.my/43888/1/LELAMEKALA%20AP%20VENGIDASAN.pdf |
Similar Items
-
The study of glucose-6-phosphate dehydrogenase (G6PD) gene by restriction enzyme by restriction enzyme digestion in the Kelantan population
by: Yusoff, Narazah Mohd, et al. -
Combinatorial Crispr/Cas9 For Suppression Of Latent Hiv-1 Provirus In Vitro
by: Ravichantar, Nithya
Published: (2020) -
Generation of human induced pluripotent stem cells (CHULAi001-A) from peripheral blood mononuclear cells of a glucose-6-phosphate dehydrogenase (G6PD) deficient subject carrying the Viangchan mutation
by: Malinee Tongbaen, et al.
Published: (2022-12-01) -
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
by: Y ZahedPasha, et al.
Published: (2006-01-01) -
Glucose-6-phosphate dehydrogenase (G6PD) Deficiency
by: DD Farhud, et al.
Published: (2008-12-01)